CureVac has reported that the ongoing Phase I study of its Covid-19 vaccine candidate CVnCoV showed that it was well-tolerated across all tested doses ranging from...
AstraZeneca has reported positive data from a subgroup analysis from Phase III DAPA-CKD trial of Farxiga (dapagliflozin) in patients with chronic kidney disease...
China has granted approval to conduct human clinical trials of the country's first nasal spray Covid-19 vaccine candidate developed by a team of researchers led by...